These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33596909)

  • 1. C
    Liang W; Wu Y; Xue R; Wu Z; Wu D; He J; Dong Y; Lip GYH; Zhu W; Liu C
    BMC Med; 2021 Feb; 19(1):44. PubMed ID: 33596909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining age stratum of the C
    Li YG; Bai J; Zhou G; Li J; Wei Y; Sun L; Zu L; Liu S
    Eur J Intern Med; 2021 Aug; 90():37-42. PubMed ID: 33975769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
    O'Neal WT; Sandesara P; Hammadah M; Venkatesh S; Samman-Tahhan A; Kelli HM; Soliman EZ
    Am J Cardiol; 2017 Jun; 119(11):1785-1790. PubMed ID: 28395886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
    Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
    JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction.
    McManus DD; Hsu G; Sung SH; Saczynski JS; Smith DH; Magid DJ; Gurwitz JH; Goldberg RJ; Go AS;
    J Am Heart Assoc; 2013 Feb; 2(1):e005694. PubMed ID: 23525446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
    Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
    Europace; 2023 May; 25(5):. PubMed ID: 37078691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Yamamoto M; Hamada-Harimura Y; Machino T; Yamasaki H; Sekiguchi Y; Nogami A; Aonuma K; Ieda M
    J Cardiol; 2019 Sep; 74(3):235-244. PubMed ID: 30910388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
    Shen L; Jhund PS; Docherty KF; Petrie MC; Anand IS; Carson PE; Desai AS; Granger CB; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Swedberg K; Zile MR; McMurray JJV
    JACC Heart Fail; 2019 May; 7(5):418-427. PubMed ID: 30981744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C
    Li YG; Bisson A; Bodin A; Herbert J; Grammatico-Guillon L; Joung B; Wang YT; Lip GYH; Fauchier L
    J Am Heart Assoc; 2019 Jul; 8(13):e012546. PubMed ID: 31234697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simple Clinical Risk Score (C
    Li YG; Pastori D; Farcomeni A; Yang PS; Jang E; Joung B; Wang YT; Guo YT; Lip GYH
    Chest; 2019 Mar; 155(3):510-518. PubMed ID: 30292759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
    Zhang X; Lv X; Wang N; Yu S; Si J; Zhang Y; Cai M; Liu Y
    Int J Cardiol; 2023 Aug; 385():34-40. PubMed ID: 37257517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
    Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C
    ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Ventricular Ejection Fraction and Clinically Defined Heart Failure to Predict 90-Day Functional Outcome After Ischemic Stroke.
    Li Y; Fitzgibbons TP; McManus DD; Goddeau RP; Silver B; Henninger N
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):371-380. PubMed ID: 30396839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
    J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
    Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.